Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Antibiotic-resistant bacteria have emerged as a serious problem; bacteriophages have, therefore, been proposed as a therapeutic alternative to antibiotics. Several authorities, such as pharmacopeia, FDA, have confirmed their safety, and some bacteriophages are commercially available worldwide. The demand for bacteriophages is expected to increase exponentially in the future; hence, there is an urgent need to mass-produce bacteriophages economically. Unlike the replication of non-lytic bacteriophages, lytic bacteriophages are replicated by lysing host bacteria, which leads to the termination of phage production; hence, strategies that can prolong the lysis of host bacteria in bacteria-bacteriophage co-cultures, are required.

Results: In the current study, we manipulated the inoculum concentrations of Staphylococcus aureus and phage pSa-3 (multiplicity of infection, MOI), and their energy sources to delay the bactericidal effect while optimizing phage production. We examined an increasing range of bacterial inoculum concentration (2 × 10 to 2 × 10 CFU/mL) to decrease the lag phase, in combination with a decreasing range of phage inoculum (from MOI 0.01 to 0.00000001) to delay the lysis of the host. Bacterial concentration of 2 × 10 CFU/mL and phage MOI of 0.0001 showed the maximum final phage production rate (1.68 × 10 plaque forming unit (PFU)/mL). With this combination of phage-bacteria inoculum, we selected glycerol, glycine, and calcium as carbon, nitrogen, and divalent ion sources, respectively, for phage production. After optimization using response surface methodology, the final concentration of the lytic Staphylococcus phage was 8.63 × 10 ± 9.71 × 10 PFU/mL (5.13-fold increase).

Conclusions: Therefore, Staphylococcus phage pSa-3 production can be maximized by increasing the bacterial inoculum and reducing the seeding phage MOI, and this combinatorial strategy could decrease the phage production time. Further, we suggest that response surface methodology has the potential for optimizing the mass production of lytic bacteriophages.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923500PMC
http://dx.doi.org/10.1186/s12934-021-01549-8DOI Listing

Publication Analysis

Top Keywords

phage production
20
response surface
12
surface methodology
12
phage
11
production
8
mass production
8
production lytic
8
lytic staphylococcus
8
staphylococcus aureus
8
multiplicity infection
8

Similar Publications

Integrative Strategies Against Multidrug-Resistant Bacteria: Synthesizing Novel Antimicrobial Frontiers for Global Health.

Microb Pathog

September 2025

Central Research Laboratory and Molecular Diagnostics, School of Allied Health Sciences, Datta Meghe Institute of Higher Education and Research, Sawangi (Meghe), Postal code 442001, Wardha, Maharashtra, India.

Concerningly, multidrug-resistant bacteria have emerged as a prime worldwide trouble, obstructing the treatment of infectious diseases and causing doubts about the therapeutic accidentalness of presently existing drugs. Novel antimicrobial interventions deserve development as conventional antibiotics are incapable of keeping pace with bacteria evolution. Various promising approaches to combat MDR infections are discussed in this review.

View Article and Find Full Text PDF

Phenotypic heterogeneity allows bacteria to adapt fast to changing environments. Extracellular capsules are well-known virulence factors, but also increase the cell adaptability and prevalence under hostile conditions. To limit their cost, some species regulate capsule production by genetic phase variation.

View Article and Find Full Text PDF

The H-NS homologues MvaT and MvaU repress CRISPR-Cas in .

Philos Trans R Soc Lond B Biol Sci

September 2025

Department of Plant and Environmental Sciences, University of Copenhagen, DK-1871 Frederiksberg, Denmark.

CRISPR-Cas is an adaptive immune system of bacteria and archaea that protects against foreign genetic elements. In and , CRISPR-Cas is inhibited by the conserved global repressor the histone-like nucleoid structuring protein (H-NS), which blocks the expression of AT-rich horizontally acquired genes. While the opportunistic pathogen harbours two partially redundant H-NS homologues, MvaT and MvaU, their role in CRISPR-Cas regulation in this bacterium remains unexplored.

View Article and Find Full Text PDF

Most type III CRISPR-Cas systems facilitate immune responses against invading mobile genetic elements such as phages by generating cyclic oligoadenylates (cOAs). Downstream effectors activated by cOAs are typically non-specific proteins that induce damage to essential cellular components, thereby preventing phage epidemics. Owing to these toxic effects, it is crucial that the production and concentration of cOAs remain under tight regulatory control during infection-free periods or when deactivating the immune response after clearing an infection.

View Article and Find Full Text PDF

Characterization of vB_SaRS_FS19-1, a newly isolated broad-host-range and virulent bacteriophage infecting Staphylococcus aureus and its application in foods.

Food Chem

August 2025

Key Laboratory of Animal Biochemistry and Nutrition, Ministry of Agriculture, College of Veterinary Medicine, Henan Agricultural University, Zhengzhou 450046, Henan province, China; Key Laboratory of Veterinary Biotechnology of Henan Province, College of Veterinary Medicine, Henan Agricultural Unive

The bacteriophage vB_SaRS_FS19-1, isolated from urban sewage, produced numerous clear plaques, about 1 to 2 mm in diameter, on the S. aureus JP19 bacterial lawn. A broad host range of the bacteriophage vB_SaRS_FS19-1 was found, and the lysis rate of S.

View Article and Find Full Text PDF